@curiancebiotch1510: Nintedanib is mainly used for treating lung-related conditions and certain cancers. Its key uses are: 1. Idiopathic Pulmonary Fibrosis (IPF) – a chronic, progressive lung disease where scar tissue builds up in the lungs, making breathing difficult. 2. Other Fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype – conditions where lung tissue becomes scarred over time. 3. Systemic Sclerosis–associated ILD (SSc-ILD) – lung scarring due to systemic sclerosis (scleroderma). 4. Advanced or metastatic non-small cell lung cancer (NSCLC) – in combination with docetaxel, for certain patients after first-line therapy. It works by blocking multiple tyrosine kinases involved in fibrosis and tumor growth. If you want, I can also explain how it slows lung scarring in simple terms.#lungcancer #IPF #lungcancerawareness